SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-23-000263
Filing Date
2023-03-16
Accepted
2023-03-16 11:26:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2849
  Complete submission text file 0001959173-23-000263.txt   4231
Mailing Address C/O TARSUS PHARMACEUTICALS, INC. 15440 LAGUNA CANYON ROAD, SUITE 160 IRVINE CA 92618
Business Address
Trevejo Jose M. (Reporting) CIK: 0001661539 (see all company filings)

Type: 144

Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Subject) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39614 | Film No.: 23737743
SIC: 2836 Biological Products, (No Diagnostic Substances)